BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Liu J, Wu R, Liang Y, Lin M, Liu J, Chan CS, Hu W, Feng Z. Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD. Oncotarget 2014;5:5535-46. [PMID: 25114038 DOI: 10.18632/oncotarget.2137] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Stempkowska A, Walicka M, Franek E, Naruszewicz M, Panczyk M, Sanchak Y, Filipek A. Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies. Genes (Basel) 2020;11:E1253. [PMID: 33114431 DOI: 10.3390/genes11111253] [Reference Citation Analysis]
2 Barnoud T, Parris JLD, Murphy ME. Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism. Oncotarget 2019;10:1217-23. [PMID: 30838093 DOI: 10.18632/oncotarget.26660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yu L, Chen X, Sun X, Wang L, Chen S. The Glycolytic Switch in Tumors: How Many Players Are Involved? J Cancer 2017;8:3430-40. [PMID: 29151926 DOI: 10.7150/jca.21125] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 15.6] [Reference Citation Analysis]
4 Gao F, Zuo Q, Jiang T, Song H, Zhou J. A newly synthesized oleanolic acid derivative inhibits the growth of osteosarcoma cells in vitro and in vivo by decreasing c-MYC-dependent glycolysis. J Cell Biochem. 2019;120:9264-9276. [PMID: 30552712 DOI: 10.1002/jcb.28202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Pinho AV, Mawson A, Gill A, Arshi M, Warmerdam M, Giry-Laterriere M, Eling N, Lie T, Kuster E, Camargo S, Biankin AV, Wu J, Rooman I. Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions. Oncotarget 2016;7:74768-78. [PMID: 27494892 DOI: 10.18632/oncotarget.11013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
6 Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Front Endocrinol (Lausanne) 2018;9:124. [PMID: 29695998 DOI: 10.3389/fendo.2018.00124] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
7 Li Y, Li B, Li CJ, Li LJ. Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors. Expert Opin Biol Ther 2015;15:437-54. [PMID: 25496374 DOI: 10.1517/14712598.2015.990882] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
8 Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget 2016;7:38908-26. [PMID: 26918353 DOI: 10.18632/oncotarget.7676] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 13.8] [Reference Citation Analysis]
9 Thamrongwaranggoon U, Sangkhamanon S, Seubwai W, Saranaruk P, Cha'on U, Wongkham S. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. In Vivo 2021;35:267-74. [PMID: 33402473 DOI: 10.21873/invivo.12255] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhao L, Mao Y, Zhao Y, Cao Y, Chen X. Role of multifaceted regulators in cancer glucose metabolism and their clinical significance. Oncotarget 2016;7:31572-85. [PMID: 26934324 DOI: 10.18632/oncotarget.7765] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
11 Corrado M, Scorrano L, Campello S. Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents. Oncotarget 2016;7:46692-706. [PMID: 27083002 DOI: 10.18632/oncotarget.8727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
12 Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W. Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma. Onco Targets Ther. 2016;9:3925-3937. [PMID: 27418837 DOI: 10.2147/ott.s106703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Arizmendi-Izazaga A, Navarro-Tito N, Jiménez-Wences H, Mendoza-Catalán MA, Martínez-Carrillo DN, Zacapala-Gómez AE, Olea-Flores M, Dircio-Maldonado R, Torres-Rojas FI, Soto-Flores DG, Illades-Aguiar B, Ortiz-Ortiz J. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants. Pathogens 2021;10:347. [PMID: 33809480 DOI: 10.3390/pathogens10030347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Janice Sánchez B, Tremblay AK, Leduc-Gaudet JP, Hall DT, Kovacs E, Ma JF, Mubaid S, Hallauer PL, Phillips BL, Vest KE, Corbett AH, Kontoyiannis DL, Hussain SNA, Hastings KEM, Di Marco S, Gallouzi IE. Depletion of HuR in murine skeletal muscle enhances exercise endurance and prevents cancer-induced muscle atrophy. Nat Commun 2019;10:4171. [PMID: 31519904 DOI: 10.1038/s41467-019-12186-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
15 Lacroix M, Riscal R, Arena G, Linares LK, Le Cam L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol Metab 2020;33:2-22. [PMID: 31685430 DOI: 10.1016/j.molmet.2019.10.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
16 Liao M, Liao W, Xu N, Li B, Liu F, Zhang S, Wang Y, Wang S, Zhu Y, Chen D, Xie W, Jiang Y, Cao L, Yang BB, Zhang Y. LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine 2019;41:200-13. [PMID: 30796006 DOI: 10.1016/j.ebiom.2019.01.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
17 Liao WL, Tan MW, Yuan Y, Wang GK, Wang C, Tang H, Xu ZY. Brahma-related gene 1 inhibits proliferation and migration of human aortic smooth muscle cells by directly up-regulating Ras-related associated with diabetes in the pathophysiologic processes of aortic dissection. J Thorac Cardiovasc Surg 2015;150:1292-301.e2. [PMID: 26344687 DOI: 10.1016/j.jtcvs.2015.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
18 Wei Z, Guo H, Qin J, Lu S, Liu Q, Zhang X, Zou Y, Gong Y, Shao C. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. Free Radical Biology and Medicine 2019;130:267-77. [DOI: 10.1016/j.freeradbiomed.2018.10.457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
19 Wang JJ, Wang Y, Hou L, Xin F, Fan B, Lu C, Zhang L, Wang F, Li S. Immunomodulatory Protein from Nectria haematococca Induces Apoptosis in Lung Cancer Cells via the P53 Pathway. Int J Mol Sci 2019;20:E5348. [PMID: 31661772 DOI: 10.3390/ijms20215348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Liu J, Zhang C, Wu R, Lin M, Liang Y, Liu J, Wang X, Yang B, Feng Z. RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. Oncotarget 2015;6:14982-92. [PMID: 25893381 DOI: 10.18632/oncotarget.3719] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
21 Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, Kello M, Mojzis J, Zubor P, Kwon TK, Shakibaei M, Büsselberg D, Sarria GR, Golubnitschaja O, Kubatka P. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J 2020;11:377-98. [PMID: 32843908 DOI: 10.1007/s13167-020-00217-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
22 Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol 2021:S1044-579X(21)00060-2. [PMID: 33785447 DOI: 10.1016/j.semcancer.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Soni S, Padwad YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncol 2017;56:503-15. [PMID: 28358664 DOI: 10.1080/0284186X.2017.1301680] [Cited by in Crossref: 109] [Cited by in F6Publishing: 84] [Article Influence: 21.8] [Reference Citation Analysis]
24 Ji H, Wang W, Li X, Han X, Zhang X, Wang J, Liu C, Huang L, Gao W. p53: A Double-Edged Sword in Tumor Ferroptosis. Pharmacol Res 2021;:106013. [PMID: 34856333 DOI: 10.1016/j.phrs.2021.106013] [Reference Citation Analysis]
25 Withers CN, Brown DM, Byiringiro I, Allen MR, Condon KW, Satin J, Andres DA. Rad GTPase is essential for the regulation of bone density and bone marrow adipose tissue in mice. Bone 2017;103:270-80. [PMID: 28732776 DOI: 10.1016/j.bone.2017.07.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Fischer M. Census and evaluation of p53 target genes. Oncogene 2017;36:3943-56. [PMID: 28288132 DOI: 10.1038/onc.2016.502] [Cited by in Crossref: 371] [Cited by in F6Publishing: 329] [Article Influence: 74.2] [Reference Citation Analysis]
27 Szołtysek K, Janus P, Zając G, Stokowy T, Walaszczyk A, Widłak W, Wojtaś B, Gielniewski B, Cockell S, Perkins ND, Kimmel M, Widlak P. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genomics 2018;19:813. [PMID: 30419821 DOI: 10.1186/s12864-018-5211-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
28 Zerdoumi Y, Kasper E, Soubigou F, Adriouch S, Bougeard G, Frebourg T, Flaman J. A new genotoxicity assay based on p53 target gene induction. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2015;789-790:28-35. [DOI: 10.1016/j.mrgentox.2015.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
29 Li X, Yu X, Dai D, Song X, Xu W. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters. Oncotarget 2016;7:23141-55. [PMID: 27009812 DOI: 10.18632/oncotarget.8153] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
30 Chang J, Lu Y, Boswell WT, Boswell M, Caballero KL, Walter RB. Molecular genetic response to varied wavelengths of light in Xiphophorus maculatus skin. Comp Biochem Physiol C Toxicol Pharmacol 2015;178:104-15. [PMID: 26460196 DOI: 10.1016/j.cbpc.2015.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Shang R, Wang J, Sun W, Dai B, Ruan B, Zhang Z, Yang X, Gao Y, Qu S, Lv X. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Tumour Biol. 2016;37:5097-5105. [PMID: 26546438 DOI: 10.1007/s13277-015-4329-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
32 Itahana Y, Itahana K. Emerging Roles of p53 Family Members in Glucose Metabolism. Int J Mol Sci 2018;19:E776. [PMID: 29518025 DOI: 10.3390/ijms19030776] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
33 Qin Y, Roszik J, Chattopadhyay C, Hashimoto Y, Liu C, Cooper ZA, Wargo JA, Hwu P, Ekmekcioglu S, Grimm EA. Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. Mol Cancer Ther 2016;15:2442-54. [PMID: 27458138 DOI: 10.1158/1535-7163.MCT-15-0963] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
34 Strycharz J, Drzewoski J, Szemraj J, Sliwinska A. Is p53 Involved in Tissue-Specific Insulin Resistance Formation? Oxid Med Cell Longev 2017;2017:9270549. [PMID: 28194257 DOI: 10.1155/2017/9270549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
35 Chen J, Cao L, Li Z, Li Y. SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake. Hum Cell 2019;32:193-201. [PMID: 30868406 DOI: 10.1007/s13577-019-00237-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
36 Jiang J, Geng G, Yu X, Liu H, Gao J, An H, Cai C, Li N, Shen D, Wu X, Zheng L, Mi Y, Yang S. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis. Oncotarget 2016;7:87271-83. [PMID: 27895313 DOI: 10.18632/oncotarget.13536] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
37 Feroz W, Sheikh AMA. Exploring the multiple roles of guardian of the genome: P53. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00089-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes Dev 2018;32:230-43. [PMID: 29463573 DOI: 10.1101/gad.309062.117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
39 Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci 2016;73:377-92. [PMID: 26499846 DOI: 10.1007/s00018-015-2070-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 131] [Article Influence: 18.4] [Reference Citation Analysis]
40 Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol 2016;231:R61-75. [PMID: 27613337 DOI: 10.1530/JOE-16-0324] [Cited by in Crossref: 66] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
41 Gutkin DW, Shurin MR, El Azher MA, Shurin GV, Velikokhatnaya L, Prosser D, Shin N, Modugno F, Stemmer P, Elishaev E, Lokshin A. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomark 2019;26:471-9. [PMID: 31658047 DOI: 10.3233/CBM-190528] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Chang L, Fang S, Gu W. The Molecular Mechanism of Metabolic Remodeling in Lung Cancer. J Cancer 2020;11:1403-11. [PMID: 32047547 DOI: 10.7150/jca.31406] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
43 Huang R, Liu X, Li H, Zhou Y, Zhou PK. Integrated analysis of transcriptomic and metabolomic profiling reveal the p53 associated pathways underlying the response to ionizing radiation in HBE cells. Cell Biosci 2020;10:56. [PMID: 32318262 DOI: 10.1186/s13578-020-00417-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Huang P, Zhu S, Liang X, Zhang Q, Luo X, Liu C, Song L. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives. Cancer Manag Res 2021;13:5317-36. [PMID: 34262341 DOI: 10.2147/CMAR.S314502] [Reference Citation Analysis]
45 Gibbs ZA, Reza LC, Cheng CC, Westcott JM, McGlynn K, Whitehurst AW. The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer. Elife 2020;9:e57679. [PMID: 32515734 DOI: 10.7554/eLife.57679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Gu NJ, Wu MZ, He L, Wang XB, Wang S, Qiu XS, Wang EH, Wu GP. HPV 16 E6/E7 up-regulate the expression of both HIF-1α and GLUT1 by inhibition of RRAD and activation of NF-κB in lung cancer cells. J Cancer 2019;10:6903-9. [PMID: 31839825 DOI: 10.7150/jca.37070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Gopu V, Fan L, Shetty RS, Nagaraja MR, Shetty S. Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis. JCI Insight 2020;5:137969. [PMID: 32841217 DOI: 10.1172/jci.insight.137969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Dhani S, Ghazi T, Nagiah S, Baijnath S, Singh SD, Chuturgoon AA. Fusaric acid alters Akt and ampk signalling in c57bl/6 mice brain tissue. Food and Chemical Toxicology 2020;138:111252. [DOI: 10.1016/j.fct.2020.111252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
49 Marín-Hernández Á, Gallardo-Pérez JC, Hernández-Reséndiz I, Del Mazo-Monsalvo I, Robledo-Cadena DX, Moreno-Sánchez R, Rodríguez-Enríquez S. Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids. J Cell Physiol 2017;232:1346-59. [PMID: 27661776 DOI: 10.1002/jcp.25617] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
50 Zhou F, Du J, Wang J. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells. Mol Cell Biochem 2017;428:171-8. [PMID: 28063005 DOI: 10.1007/s11010-016-2927-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
51 Liu J, Zhang C, Hu W, Feng Z. Tumor suppressor p53 and metabolism. J Mol Cell Biol 2019;11:284-92. [PMID: 30500901 DOI: 10.1093/jmcb/mjy070] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 19.0] [Reference Citation Analysis]
52 Zhang C, Liu J, Wang J, Zhang T, Xu D, Hu W, Feng Z. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Front Cell Dev Biol 2021;9:648808. [PMID: 33681231 DOI: 10.3389/fcell.2021.648808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]